Paolo P
Chairman of the Scientific Committee
Medical Sciences
Genmab
Denmark
Biography
Special Competences Extensive experience in research, development and commercialization in the pharmaceutical industry. Successfully conducted submissions and approvals of new cancer drugs and new indications in the USA and in Europe. Responsible for seven new medicines for cancer patients during his 10 years at GlaxoSmithKline and one new cancer medicine during his time at Eli Lilly. Current Position, including Managerial Positions CEO of GammaDelta Therapeutics Limited Current Board Positions Chairman: PsiOxus Therapeutics Limited Member: FORMA Therapeutics and NuCana BioMed Limited
Research Interest
Medical Sciences
